ForFish jump medical treatmentAs far as the first half of 2021 is concerned, it has been a fruitful half year. As can be seen from the financial results released by Yuyue Medical in the first half of 2021, Yuyue Medical achieved an operating income of 3.593 billion yuan in the first half of 2021 alone, an increase of 5% over the same period last year.Net profitUp to 963 million yuan. These positive growth is still based on another jump in the ultra-high base brought about by the outbreak of the epidemic in 2020, which shows that Yuyue Medical has achieved a steady increase in performance.
From the first-half results of Yuyue Medical, it is not difficult to see that Yuyue Medical has not only achieved positive growth in operating income and net profit that exceeded market expectations in 2021, but also made a new breakthrough in the scale of assets. In the first half of the year, the monetary fund of Yuyue Medical reached 3.152 billion yuan, and the total assets reached 11.427 billion yuan. Compared with the data of the past few years, Yuyue Medical's revenue and assets are growing steadily. Specifically from the business plate of Yuyue Medical, Yuyue Medical currently focuses on the development of respiratory, blood sugar and disinfection control plate have varying degrees of growth. Among them, revenue from the breathing sector increased by 13.52% over the same period last year, while revenue from the blood sugar sector increased by 130.15% compared with the same period last year.
Under the environment that the external economy is not optimistic, Yuyue Medical has achieved gratifying results in the first half of 2021, which is closely related to its strategic adjustment in the first half of the year. In the first half of 2021, Wu Qun, chairman of Yuyue Medical, announced that Yuyue will focus on three core tracks in the future, such as blood pressure monitoring, body temperature monitoring, traditional Chinese medicine equipment, surgical instruments and so on: respiratory treatment solutions, diabetes, and sensory-controlled disinfection. In addition, high potential businesses such as first aid, ophthalmology and intelligent rehabilitation will continue to be incubated. The characteristic product line makes Yuyue Medical not only has a wider and wider audience at home, but also plays an important role in the international market. At the same time, Yuyue Medical continues to increase its investment in R & D. in the first half of 2021 alone, Yuyue Medical's investment in R & D reached 180 million yuan. Based on the investment in research and development, Yuyue Medical will have more breakthrough mid-and high-end products in the future. For example, in May this year, Yuyue Medical released four very eye-catching new products: Annaitang Anytime- continuous blood glucose monitor, portable oxygen machine Spirit-3, household high-flow respiratory humidification therapy device HF-60M and automatic external defibrillator-M600, and the market response is very good.
Yuyue Medical has achieved a dazzling transcript in the first half of 2021, and it is believed that the performance of Yuyue Medical will be equally remarkable in the following second half of the year. According to the development momentum of Yuyue Medical in recent years, especially the strong strength and the responsibility of large enterprises after the epidemic, we can see that Yuyue Medical will have a broader road in the future.